The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Alzheimer's Disease-Global Market Insights and Sales Trends 2024
Synopsis
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
The global Alzheimer's Disease market size is expected to reach US$ 4024.3 million by 2029, growing at a CAGR of 1.5% from 2023 to 2029. The market is mainly driven by the significant applications of Alzheimer's Disease in various end use industries. The expanding demands from the Early to Moderate Stages and Moderate to Severe Stages, are propelling Alzheimer's Disease market. Donepezil, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Memantine segment is estimated at % CAGR for the next seven-year period.
The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Alzheimer's Disease, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Alzheimer's Disease market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Alzheimer's Disease market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Alzheimer's Disease sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Alzheimer's Disease covered in this report include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson and Lundbeck, etc.
The global Alzheimer's Disease market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Global Alzheimer's Disease market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Alzheimer's Disease market, Segment by Type:
Donepezil
Memantine
Rivastigmine
Global Alzheimer's Disease market, by Application
Early to Moderate Stages
Moderate to Severe Stages
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Alzheimer's Disease companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
The global Alzheimer's Disease market size is expected to reach US$ 4024.3 million by 2029, growing at a CAGR of 1.5% from 2023 to 2029. The market is mainly driven by the significant applications of Alzheimer's Disease in various end use industries. The expanding demands from the Early to Moderate Stages and Moderate to Severe Stages, are propelling Alzheimer's Disease market. Donepezil, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Memantine segment is estimated at % CAGR for the next seven-year period.
The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Alzheimer's Disease, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Alzheimer's Disease market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Alzheimer's Disease market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Alzheimer's Disease sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Alzheimer's Disease covered in this report include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson and Lundbeck, etc.
The global Alzheimer's Disease market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Global Alzheimer's Disease market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Alzheimer's Disease market, Segment by Type:
Donepezil
Memantine
Rivastigmine
Global Alzheimer's Disease market, by Application
Early to Moderate Stages
Moderate to Severe Stages
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Alzheimer's Disease companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Alzheimer's Disease
1.1 Alzheimer's Disease Market Overview
1.1.1 Alzheimer's Disease Product Scope
1.1.2 Alzheimer's Disease Market Status and Outlook
1.2 Global Alzheimer's Disease Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Alzheimer's Disease Market Size by Region (2018-2029)
1.4 Global Alzheimer's Disease Historic Market Size by Region (2018-2023)
1.5 Global Alzheimer's Disease Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Alzheimer's Disease Market Size (2018-2029)
1.6.1 North America Alzheimer's Disease Market Size (2018-2029)
1.6.2 Europe Alzheimer's Disease Market Size (2018-2029)
1.6.3 Asia-Pacific Alzheimer's Disease Market Size (2018-2029)
1.6.4 Latin America Alzheimer's Disease Market Size (2018-2029)
1.6.5 Middle East & Africa Alzheimer's Disease Market Size (2018-2029)
2 Alzheimer's Disease Market by Type
2.1 Introduction
2.1.1 Donepezil
2.1.2 Memantine
2.1.3 Rivastigmine
2.2 Global Alzheimer's Disease Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Alzheimer's Disease Historic Market Size by Type (2018-2023)
2.2.2 Global Alzheimer's Disease Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Alzheimer's Disease Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Alzheimer's Disease Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Alzheimer's Disease Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Alzheimer's Disease Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Alzheimer's Disease Revenue Breakdown by Type (2018-2029)
3 Alzheimer's Disease Market Overview by Application
3.1 Introduction
3.1.1 Early to Moderate Stages
3.1.2 Moderate to Severe Stages
3.2 Global Alzheimer's Disease Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Alzheimer's Disease Historic Market Size by Application (2018-2023)
3.2.2 Global Alzheimer's Disease Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Alzheimer's Disease Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Alzheimer's Disease Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Alzheimer's Disease Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Alzheimer's Disease Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Alzheimer's Disease Revenue Breakdown by Application (2018-2029)
4 Alzheimer's Disease Competition Analysis by Players
4.1 Global Alzheimer's Disease Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alzheimer's Disease as of 2022)
4.3 Date of Key Players Enter into Alzheimer's Disease Market
4.4 Global Top Players Alzheimer's Disease Headquarters and Area Served
4.5 Key Players Alzheimer's Disease Product Solution and Service
4.6 Competitive Status
4.6.1 Alzheimer's Disease Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Allergan
5.1.1 Allergan Profile
5.1.2 Allergan Main Business
5.1.3 Allergan Alzheimer's Disease Products, Services and Solutions
5.1.4 Allergan Alzheimer's Disease Revenue (US$ Million) & (2018-2023)
5.1.5 Allergan Recent Developments
5.2 Eisai
5.2.1 Eisai Profile
5.2.2 Eisai Main Business
5.2.3 Eisai Alzheimer's Disease Products, Services and Solutions
5.2.4 Eisai Alzheimer's Disease Revenue (US$ Million) & (2018-2023)
5.2.5 Eisai Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Alzheimer's Disease Products, Services and Solutions
5.3.4 Novartis Alzheimer's Disease Revenue (US$ Million) & (2018-2023)
5.3.5 Daiichi Sankyo Recent Developments
5.4 Daiichi Sankyo
5.4.1 Daiichi Sankyo Profile
5.4.2 Daiichi Sankyo Main Business
5.4.3 Daiichi Sankyo Alzheimer's Disease Products, Services and Solutions
5.4.4 Daiichi Sankyo Alzheimer's Disease Revenue (US$ Million) & (2018-2023)
5.4.5 Daiichi Sankyo Recent Developments
5.5 Merz Pharma
5.5.1 Merz Pharma Profile
5.5.2 Merz Pharma Main Business
5.5.3 Merz Pharma Alzheimer's Disease Products, Services and Solutions
5.5.4 Merz Pharma Alzheimer's Disease Revenue (US$ Million) & (2018-2023)
5.5.5 Merz Pharma Recent Developments
5.6 Pfizer
5.6.1 Pfizer Profile
5.6.2 Pfizer Main Business
5.6.3 Pfizer Alzheimer's Disease Products, Services and Solutions
5.6.4 Pfizer Alzheimer's Disease Revenue (US$ Million) & (2018-2023)
5.6.5 Pfizer Recent Developments
5.7 Johnson & Johnson
5.7.1 Johnson & Johnson Profile
5.7.2 Johnson & Johnson Main Business
5.7.3 Johnson & Johnson Alzheimer's Disease Products, Services and Solutions
5.7.4 Johnson & Johnson Alzheimer's Disease Revenue (US$ Million) & (2018-2023)
5.7.5 Johnson & Johnson Recent Developments
5.8 Lundbeck
5.8.1 Lundbeck Profile
5.8.2 Lundbeck Main Business
5.8.3 Lundbeck Alzheimer's Disease Products, Services and Solutions
5.8.4 Lundbeck Alzheimer's Disease Revenue (US$ Million) & (2018-2023)
5.8.5 Lundbeck Recent Developments
6 North America
6.1 North America Alzheimer's Disease Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Alzheimer's Disease Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer's Disease Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Alzheimer's Disease Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer's Disease Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Alzheimer's Disease Market Dynamics
11.1 Alzheimer's Disease Industry Trends
11.2 Alzheimer's Disease Market Drivers
11.3 Alzheimer's Disease Market Challenges
11.4 Alzheimer's Disease Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
